Flecainide toxicity late after liver transplantation

Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, mal...

Full description

Saved in:
Bibliographic Details
Published inProceedings - Baylor University. Medical Center Vol. 34; no. 3; pp. 378 - 379
Main Authors Elsaid, Ossama, Tecson, Kristen M., Khan, Hafiza, Assar, Manish D.
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis Ltd 22.01.2021
Taylor & Francis
Subjects
Cardiac arrhythmia
Case Report
Case Studies
Liver transplants
Toxicity
Antiarrhythmic
flecainide
supraventricular tachycardia
Online AccessGet full text
ISSN0899-8280
1525-3252
DOI10.1080/08998280.2020.1871266

Cover

Abstract Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, malaise, dizziness, visual disturbance, nausea, vomiting, and/or lethargy. It carries an associated mortality rate of approximately 10%. Herein, we describe the course of a patient who experienced flecainide toxicity in the setting of renal and liver failure.
AbstractList Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, malaise, dizziness, visual disturbance, nausea, vomiting, and/or lethargy. It carries an associated mortality rate of approximately 10%. Herein, we describe the course of a patient who experienced flecainide toxicity in the setting of renal and liver failure.
Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, malaise, dizziness, visual disturbance, nausea, vomiting, and/or lethargy. It carries an associated mortality rate of approximately 10%. Herein, we describe the course of a patient who experienced flecainide toxicity in the setting of renal and liver failure.Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, malaise, dizziness, visual disturbance, nausea, vomiting, and/or lethargy. It carries an associated mortality rate of approximately 10%. Herein, we describe the course of a patient who experienced flecainide toxicity in the setting of renal and liver failure.
Author Elsaid, Ossama
Tecson, Kristen M.
Khan, Hafiza
Assar, Manish D.
Author_xml – sequence: 1
  givenname: Ossama
  orcidid: 0000-0002-8112-1247
  surname: Elsaid
  fullname: Elsaid, Ossama
  organization: Division of Cardiology, Department of Internal Medicine, Baylor University Medical Center, Dallas, Texas
– sequence: 2
  givenname: Kristen M.
  orcidid: 0000-0002-6732-8698
  surname: Tecson
  fullname: Tecson, Kristen M.
  organization: Baylor Heart and Vascular Institute, Baylor Scott & White Research Institute, Dallas, Texas, Department of Internal Medicine, Texas A&M Health Science Center College of Medicine, Dallas, Texas
– sequence: 3
  givenname: Hafiza
  surname: Khan
  fullname: Khan, Hafiza
  organization: Division of Cardiology, Department of Internal Medicine, Baylor Heart and Vascular Hospital, Plano, Texas
– sequence: 4
  givenname: Manish D.
  surname: Assar
  fullname: Assar, Manish D.
  organization: Division of Cardiology, Department of Internal Medicine, Baylor University Medical Center, Dallas, Texas, Department of Internal Medicine, Texas A&M Health Science Center College of Medicine, Dallas, Texas
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33953467$$D View this record in MEDLINE/PubMed
BookMark eNp9kU9LAzEQxYMo9o9-BKXgxcvWSbLZzSIIUqwKghc9h2w20ZRtUjfbYr-9WduK9uAlgeQ3M2_eG6BD551G6AzDGAOHK-BFwQmHMQESn3iOSZYdoD5mhCWUMHKI-h2TdFAPDUKYAaSY4vwY9SgtGE2zvI_Saa2VtM5WetT6T6tsux7VstUjaVrdjGq7imfbSBcWtXStbK13J-jIyDro0-09RK_Tu5fJQ_L0fP84uX1KFGVplpgs5QXRBlcGKDDKMDUMY8ZkSitVMpxqAqqiVQU0BwMYE60UmKosSl5yRofoZtN3sSznulLaRSG1WDR2Lpu18NKKvz_Ovos3vxIcWFFgiA0utw0a_7HUoRVzG5Su4ybaL4OINpGMQJF3sy720JlfNi6uFymcAU8jGKnz34p-pOwMjcD1BlCND6HRRkRHv02LAm0tMIguPrGLT3TxiW18sZrtVe8G_F_3BemGnBE
CitedBy_id crossref_primary_10_7759_cureus_37184
Cites_doi 10.1111/j.1742-6723.2006.00909.x
10.1136/emj.2006.044362
10.1007/s00228-015-1832-0
10.1016/0002-9149(92)91072-C
10.1056/NEJM198607033150106
10.1111/j.1540-8159.2012.03485.x
10.3109/15563659009038586
10.3109/17482941.2013.841949
10.1038/clpt.1988.57
ContentType Journal Article
Copyright Copyright © 2021 Baylor University Medical Center.
Copyright © 2021 Baylor University Medical Center
Copyright © 2021 Baylor University Medical Center 2021 Baylor University Medical Center
Copyright_xml – notice: Copyright © 2021 Baylor University Medical Center.
– notice: Copyright © 2021 Baylor University Medical Center
– notice: Copyright © 2021 Baylor University Medical Center 2021 Baylor University Medical Center
DBID AAYXX
CITATION
NPM
K9.
7X8
5PM
DOI 10.1080/08998280.2020.1871266
DatabaseName CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed

ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Flecainide Toxicity Late After Liver Transplantation
EISSN 1525-3252
EndPage 379
ExternalDocumentID PMC8059910
33953467
10_1080_08998280_2020_1871266
Genre Case Reports
GroupedDBID 04C
0R~
29O
2WC
36B
5VS
6PF
7X7
8FI
AAGDL
AAMIU
AAPUL
AAQRR
AAWTL
AAYXX
ABBKH
ABEIZ
ABLIJ
ABUPF
ABWVI
ABXYU
ACENM
ACIEZ
ADCVX
ADOJX
ADYSH
AECIN
AFKRA
AFRVT
AGDLA
AGFJD
AGRBW
AGYJP
AHMBA
AIRBT
AKBVH
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMDAE
BENPR
BLEHA
BPHCQ
BVXVI
CCCUG
CITATION
DIK
E3Z
EBS
ECT
EIHBH
F5P
FRP
FYUFA
H13
HYE
IAO
IHR
INH
INR
KQ8
KYCEM
LJTGL
M4Z
MK0
OK1
OVT
PQQKQ
PROAC
RNANH
RNS
RPM
RVRKI
TBQAZ
TERGH
TFW
TUROJ
UEQFS
NPM
K9.
TASJS
7X8
5PM
ID FETCH-LOGICAL-c3546-f64892ef1df03053513f51155a43dcb514e20cd3dd0370f0112ecc0fdb9b8b853
ISSN 0899-8280
IngestDate Thu Aug 21 18:21:08 EDT 2025
Thu Sep 04 18:15:55 EDT 2025
Wed Aug 13 08:45:43 EDT 2025
Thu Apr 03 07:07:24 EDT 2025
Tue Jul 01 04:22:14 EDT 2025
Thu Apr 24 23:08:48 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Antiarrhythmic
flecainide
supraventricular tachycardia
Language English
License Copyright © 2021 Baylor University Medical Center.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3546-f64892ef1df03053513f51155a43dcb514e20cd3dd0370f0112ecc0fdb9b8b853
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Report-3
ObjectType-Case Study-4
ObjectType-Case Study-2
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
The authors report no conflicts of interest. The patient’s husband granted permission to publish this case report.
ORCID 0000-0002-6732-8698
0000-0002-8112-1247
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8059910
PMID 33953467
PQID 2516084620
PQPubID 1046400
PageCount 2
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8059910
proquest_miscellaneous_2522620975
proquest_journals_2516084620
pubmed_primary_33953467
crossref_citationtrail_10_1080_08998280_2020_1871266
crossref_primary_10_1080_08998280_2020_1871266
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210122
PublicationDateYYYYMMDD 2021-01-22
PublicationDate_xml – month: 1
  year: 2021
  text: 20210122
  day: 22
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Dallas
PublicationTitle Proceedings - Baylor University. Medical Center
PublicationTitleAlternate Proc (Bayl Univ Med Cent)
PublicationYear 2021
Publisher Taylor & Francis Ltd
Taylor & Francis
Publisher_xml – name: Taylor & Francis Ltd
– name: Taylor & Francis
References CIT0010
CIT0001
CIT0003
CIT0002
CIT0005
CIT0004
Grande A (CIT0007) 2010; 14
CIT0006
CIT0009
CIT0008
References_xml – ident: CIT0008
  doi: 10.1111/j.1742-6723.2006.00909.x
– ident: CIT0005
  doi: 10.1136/emj.2006.044362
– volume: 14
  start-page: 25
  issue: 1
  year: 2010
  ident: CIT0007
  publication-title: Eur Rev Med Pharmacol Sci
– ident: CIT0003
  doi: 10.1007/s00228-015-1832-0
– ident: CIT0006
  doi: 10.1016/0002-9149(92)91072-C
– ident: CIT0001
  doi: 10.1056/NEJM198607033150106
– ident: CIT0009
  doi: 10.1111/j.1540-8159.2012.03485.x
– ident: CIT0004
  doi: 10.3109/15563659009038586
– ident: CIT0010
  doi: 10.3109/17482941.2013.841949
– ident: CIT0002
  doi: 10.1038/clpt.1988.57
SSID ssj0041317
Score 2.1442394
Snippet Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 378
SubjectTerms Cardiac arrhythmia
Case Report
Case Studies
Liver transplants
Toxicity
Title Flecainide toxicity late after liver transplantation
URI https://www.ncbi.nlm.nih.gov/pubmed/33953467
https://www.proquest.com/docview/2516084620
https://www.proquest.com/docview/2522620975
https://pubmed.ncbi.nlm.nih.gov/PMC8059910
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBZtCiEvpXedpsWFvgUvtg4fjz1SlpZt-7CBvBnZkohh4yz1Bkp-fWYk-dhNSo8Xs0iWvGhGo5nRzHyEvKsVFQrh23mV4TVjQqMiNSLSwF6U5rlRFrRv8S2dn_IvZ-JsDGu22SWbalZf35lX8j9UhTagK2bJ_gNlh0mhAX4DfeEJFIbnX9EYFr1GhAeF-Be_mtrCQIDy6JG_VxhzgSAQbbdeyXZy6e610R_D6dUdR8cfHNzGGKoxG65x0Ac8hvGerDrZWM743nVyFOxLXfv8LSs6dDu6Wr-eO0frXJrmehgAvOHiuxeyxcpKn6Y-CIoOiIhO3ZJgtWFCejyVq95J2UzNbiskmQPtuSW8fbQjWoAwFdjuFBrBoKMOl2VC0PWFpShjhWDcwXnsVM3uu-6TBzRLU9r7cdwZDSd34mrA-v_d53Zh1fW7vn9A9vsZtxWYW1bJbnDtRFtZPiIPvZkRvnc885jc0-0Tsr_wgRRPCR9ZJ-xZJ0TWCS3rhJZ1wh3WeUZOP58sP84jD6AR1UzwNDIpzwuqTaIMynUmEmZAwRZCcqbqCnRlTeNaMaVilsUGRD2FHR0bVRVVXoEi95zstZetfklCVqQaAzYM04JXlSwyCao-Vv9LFVZTCAjvV6WsfXV5BDlZlUlfhNava4nrWvp1DchsGLZ25VX-NOCoX_LS78SuBB09jUGRpnFA3g7dICfx8ku2-vIK36GIvVBkIiAvHIWGL_akDUi2RbvhBazBvt3TNue2FnuO9Y2S-PC3c74iB-OOOSJ7m59X-jXosZvqjWXJG2PylKU
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flecainide+toxicity+late+after+liver+transplantation&rft.jtitle=Proceedings+-+Baylor+University.+Medical+Center&rft.au=Elsaid%2C+Ossama&rft.au=Tecson%2C+Kristen+M&rft.au=Khan%2C+Hafiza&rft.au=Assar%2C+Manish+D&rft.date=2021-01-22&rft.issn=0899-8280&rft.volume=34&rft.issue=3&rft.spage=378&rft_id=info:doi/10.1080%2F08998280.2020.1871266&rft_id=info%3Apmid%2F33953467&rft.externalDocID=33953467
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0899-8280&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0899-8280&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0899-8280&client=summon